Perfil
Pieter Spee is currently the Chief Scientific Officer at Pure Biologics SA since 2023.
Prior to this, he worked as the Scientific Director-Translational Immunology at Novo Nordisk A, Chief Scientific Officer at TikoMed AB, and Chief Technology Officer at FibroTx OÜ.
He obtained his doctorate degree from the University of Leiden in 1996.
Cargos activos de Pieter Spee
| Empresas | Cargo | Inicio |
|---|---|---|
| PURE BIOLOGICS S.A. | Director Técnico/Científico/I+D | 26/05/2023 |
Antiguos cargos conocidos de Pieter Spee.
| Empresas | Cargo | Fin |
|---|---|---|
FibroTx OÜ | Director Técnico/Científico/I+D | - |
TikoMed AB
TikoMed AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director Técnico/Científico/I+D | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Formación de Pieter Spee.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TikoMed AB
TikoMed AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Pure Biologics SA
Pure Biologics SA BiotechnologyHealth Technology Operates as a a biopharmaceutical company which develops biological medicines, diagnostic tests and medical devices with therapeutic use | Health Technology |
FibroTx OÜ |
- Bolsa de valores
- Insiders
- Pieter Spee
















